Go Back
PRECISION BIOSCIENCES INC reports $25.1 million Q1 loss
By USInMinutes - May 09, 2023, 04:13 PM ET
Last Updated - Jul 18, 2023, 03:32 PM EDT
The company generated $8.80 million in quarterly revenue
PRECISION BIOSCIENCES INC [DTIL] has reported fiscal Q1 loss of $25.10 million.
On a per-share basis, the DE based company said its diluted earnings are $0.23.
The Biological Products, Except Diagnostic Substances firm posted revenue of $8.80 million in this period.
Also Read:
- Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Precision BioSciences to Report First Quarter 2023 Results on May 9, 2023
- Precision BioSciences to Present Preclinical In Vivo Gene Editing Research for its ARCUS HBV Program at Upcoming Global Hepatitis Summit 2023
- Precision BioSciences Announces Late-Breaking Abstract of Preclinical In Vivo Gene Editing Research Selected for Oral Presentation at the American Society of Gene & Cell Therapy 26th Annual Meeting
- Precision BioSciences Announces Late-Breaking Abstract of Preclinical In Vivo Gene Editing Research Selected for Oral Presentation at the American Society of Gene & Cell Therapy 26th Annual Meeting
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News